Komori
Pharmarise Holdings (2796) · FactDeclining Revenue and Widening Losses in Other Businesses

Expansion of Systems Integration Services for Pharmaceutical Companies

First written in FY2018-Q2. 4 of 30 entries say "Advanced", first in FY2018. Latest entry: FY2026.

30entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2021-Q1 – FY20262018: 420182019: 320192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Deteriorating profitability in the system integration business for pharmaceutical companiesA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Declining Revenue and Widening Losses in Other BusinessesAnnual report

    「As a result, in the current consolidated fiscal year, revenue from Other businesses was ¥986 million, down 7.3% year on year, while segment results were a ¥113 million loss, compared with a ¥52 million loss in the previous year.」

    Other businesses reported lower revenue and wider losses due to the fee-based employment placement, home-visit nursing and healthcare-related IT solutions businesses and other operations.
  2. FY2026-H1Declining Revenue and Widening Losses in Other BusinessesAnnual report

    「In the current interim consolidated accounting period, revenue from Other businesses was ¥459 million, down 15.7% year on year, while segment results were a ¥92 million loss, compared with a ¥6 million loss in the same period of the previous year.」

    Other businesses reported lower revenue and wider losses due to fewer employment placement and staffing contracts, fewer home-visit nursing visits and new product development costs in the healthcare-related IT business and other factors.
  3. FY2025Higher revenue and wider losses in Other businessesAnnual report

    「Revenue from Other businesses was ¥1,064 million, up 27.5% year on year, while segment results were a ¥52 million loss, compared with a ¥5 million loss in the same period of the previous year.」

    Revenue increased following the addition of day-care services, home-visit nursing and fee-based nursing home operations and other businesses, while losses widened as new product development costs in the healthcare-related IT solutions business were incurred ahead of revenue.
  4. FY2025-H1Other businesses: higher revenue and shift to a lossAnnual report

    「In the current interim consolidated accounting period, revenue from Other businesses was ¥544 million, up 39.9% year on year, while segment results were a ¥6 million loss, compared with profit of ¥2 million in the same period of the previous year.」

    Other businesses reported higher revenue, but shifted from a ¥2 million profit in the same period of the previous year to a ¥6 million loss. Day-care services, home-visit nursing and fee-based nursing home operations and other businesses were newly added, while new product development costs in the healthcare-related IT solutions business were incurred ahead of revenue.
  5. FY2024Other businesses: higher revenue and shift to a lossAnnual report

    「Revenue was ¥834 million, up 7.1% year on year, while segment results were a ¥5 million loss, compared with segment profit of ¥36 million in the same period of the previous year.」

    Other businesses reported higher revenue, but shifted from a ¥36 million profit to a ¥5 million loss due to lower profit in the healthcare-related IT solutions business and other operations.
  6. FY2024-Q3Higher revenue and a sharp decline in profit in Other businessesAnnual report

    「In the first 3 quarters of the current consolidated fiscal year, revenue from Other businesses was ¥593 million, up 3.4% year on year, mainly due to higher revenue in the system integration business and the healthcare-related IT solutions business. However, segment profit was ¥5 million, down 84.2%, due mainly to lower profit in the fee-based employment placement business following its strong performance in the third quarter of the previous fiscal year.」

    Other businesses reported higher revenue due to increased revenue in the system integration and healthcare-related IT solutions businesses, while profit fell substantially due mainly to the reaction to the fee-based employment placement business's lower profit.
  7. FY2024-Q2Higher revenue and a sharp decline in profit in Other businessesAnnual report

    「In the first 2 quarters of the current consolidated fiscal year, revenue from Other businesses was ¥389 million, up 3.8% year on year, due to strong performance in the staffing business. Meanwhile, segment profit was ¥2 million, down 90.4%, due to fewer pharmaceutical wholesale transactions and lower profit in the healthcare-related IT solutions business and other operations.」

    Other businesses reported higher revenue on strong performance in the staffing business, but profit fell substantially due to fewer wholesale transactions and lower profit in the healthcare-related IT solutions business.
  8. FY2024-Q1Other businesses: lower revenue and elimination of profitAnnual report

    「In the first quarter of the current consolidated fiscal year, revenue from Other businesses was ¥185 million, down 9.2% year on year, due to the reaction to the fee-based employment placement business's strong performance in the same period of the previous fiscal year. In addition, segment profit was ¥0 million, down 95.7%, due to the decline in pharmaceutical wholesale transactions and lower profit in the healthcare-related IT solutions business and other operations.」

    Other businesses reported lower revenue due to the reaction to the previous period's strong performance in the fee-based employment placement business, fewer pharmaceutical wholesale transactions and lower profit in the healthcare-related IT solutions business and other operations. Segment profit was ¥0 million.
  9. FY2023Lower Revenue and Profit in Other BusinessesAnnual report

    「In the current consolidated fiscal year, revenue from Other businesses was ¥779 million, down 3.1% year on year, mainly due to lower revenue from pharmaceutical wholesale transactions, despite strong performance in the fee-based employment placement business. Segment profit was ¥36 million, down 53.7%, due mainly to the decline in pharmaceutical wholesale revenue and lower profit in the healthcare-related IT solutions business and other operations.」

    Other businesses reported lower revenue and profit. The fee-based employment placement business performed well, but wholesale transactions and the healthcare-related IT solutions business and other operations weighed on results.
  10. FY2023-Q3Revenue and Profit Growth in Other BusinessesAnnual report

    「In the first 3 quarters of the current consolidated fiscal year, revenue from Other businesses was ¥573 million, up 2.3% year on year, mainly because the employment placement business was able to meet growing demand for DX personnel. In addition, segment profit was ¥37 million, up 62.6%, as the system integration business reduced its loss.」

    Other businesses reported higher revenue and profit, reflecting the response to demand for DX personnel and a reduced loss in the system integration business.
  11. FY2023-Q2Lower revenue and higher profit in Other businessesAnnual report

    「In the cumulative consolidated period through the second quarter, Other businesses generated revenue of ¥375 million, down 14.3% year on year, mainly because of lower revenue from pharmaceutical wholesale transactions. Segment profit was ¥26 million, up 94.7% year on year, due to higher profit in the systems integration business and healthcare-related IT solutions business, among others.」

    Other businesses posted lower revenue because of lower pharmaceutical wholesale revenue, while segment profit increased to ¥26 million due to higher profit in the systems integration and healthcare-related IT solutions businesses, among others.
  12. FY2023-Q1Lower revenue and a return to profitability in Other businessesAnnual report

    「In the cumulative consolidated period through the first quarter, Other businesses generated revenue of ¥204 million, down 25.0% year on year, and segment profit of ¥21 million, compared with a segment loss of ¥8 million in the same period of the previous year.」

    Other businesses posted lower revenue, while turning from a loss of ¥8 million in the same period of the previous year to profit of ¥21 million.
  13. FY2022Higher revenue and slight profit growth in Other businessesAnnual report

    「In the consolidated fiscal year, Other businesses generated revenue of ¥764 million, up 6.8% year on year, and segment profit of ¥41 million, up 1.0% year on year.」

    Other businesses, including healthcare IT, staffing and fee-based employment placement services, posted higher revenue, while segment profit edged up to ¥41 million.
  14. FY2022-Q3Higher revenue and a sharp decline in profit in Other businessesAnnual report

    「In the cumulative consolidated period through the third quarter, Other businesses generated revenue of ¥534 million, up 16.4% year on year, and segment profit of ¥1 million, down 92.1% year on year.」

    Other businesses posted higher revenue, while segment profit fell 92.1% year on year to ¥1 million.
  15. FY2022-Q2Higher sales and a narrower loss in Other BusinessesAnnual report

    「In the cumulative consolidated period through the second quarter, Other businesses generated revenue of ¥365 million, up 17.1% year on year, and a segment loss of ¥5 million, compared with a segment loss of ¥23 million in the same period of the previous year.」

    Other businesses posted higher revenue, while the segment loss narrowed from ¥23 million in the same period of the previous year to ¥5 million.
  16. FY2022-Q1Higher revenue and wider losses in Other businessesAnnual report

    「In the cumulative consolidated period through the first quarter, Other businesses generated revenue of ¥173 million, up 10.7% year on year, and a segment loss of ¥13 million, compared with a segment loss of ¥8 million in the same period of the previous year.」

    Other businesses, including healthcare IT, staffing and fee-based employment placement services, posted higher revenue, while the segment loss widened from ¥8 million in the same period of the previous year to ¥13 million.
  17. FY2021Higher revenue and a return to profitability in Other businessesAnnual report

    「In the consolidated fiscal year, Other businesses generated revenue of ¥716 million, up 14.8% year on year, and segment profit of ¥40 million, compared with a segment loss of ¥6 million in the previous year.」

    Other businesses, including healthcare IT, staffing and fee-based employment placement services, posted higher revenue and turned from a loss of ¥6 million in the previous year to profit of ¥40 million.
  18. FY2021-Q3Slightly lower revenue and a return to profitability in Other businessesAnnual report

    「In the cumulative consolidated period through the third quarter, Other businesses generated revenue of ¥459 million, down 0.3% year on year, and segment profit of ¥19 million, compared with a segment loss of ¥23 million in the same period of the previous year.」

    Other businesses, including healthcare IT, staffing and fee-based employment placement services, posted slightly lower revenue, while turning from a loss of ¥23 million in the same period of the previous year to profit of ¥19 million.
  19. FY2021-Q2Higher revenue and wider losses in Other businessesAnnual report

    「In the cumulative consolidated period through the second quarter, Other businesses generated revenue of ¥312 million, up 4.5% year on year, and a segment loss of ¥23 million, compared with a segment loss of ¥8 million in the same period of the previous year.」

    Other businesses, including healthcare IT, staffing and fee-based employment placement services, posted higher revenue, while the segment loss widened from ¥8 million to ¥23 million.
  20. FY2021-Q1Higher sales and a narrower loss in Other BusinessesAnnual report

    「In the cumulative consolidated period through the first quarter, Other businesses generated revenue of ¥156 million, up 15.7% year on year, and a segment loss of ¥8 million, compared with a segment loss of ¥27 million in the same period of the previous year.」

    Other businesses, including healthcare IT, staffing and fee-based employment placement services, posted higher revenue, while the segment loss narrowed from ¥27 million to ¥8 million.
  21. FY2020AdvancedAnnual report

    「In Other businesses, on 1 October 2019, the Company acquired shares in 株式会社メディカルフロント, a healthcare IT solutions company whose main product is the electronic medication record app "ポケットファーマシー" and an equity-method affiliate of the Company, and made it a consolidated subsidiary.」

    The Company made メディカルフロント, a healthcare IT solutions company, a consolidated subsidiary, bringing healthcare IT, including electronic medication records, into the Group.
  22. FY2020-Q3AdvancedAnnual report

    「On 31 March 2020, the Company acquired shares in 株式会社ウィーク, which provides staffing services, including SEs for medical representative and IT companies, as well as fee-based employment placement services, and made it a consolidated subsidiary.」

    The Company made 株式会社ウィーク, which provides SE staffing services for medical representative and IT companies and fee-based employment placement services, a consolidated subsidiary, expanding the human resources and IT areas of Other businesses.
  23. FY2020-Q2Lower revenue and a segment loss in Other businessesAnnual report

    「In the cumulative consolidated period through the second quarter, Other businesses generated revenue of ¥298 million, down 7.2% year on year, and a segment loss of ¥8 million, compared with a segment loss of ¥0 million in the same period of the previous year.」

    Other businesses, including the healthcare-related IT businesses of ミュートス and メディカルフロント, posted lower revenue and recorded a segment loss of ¥8 million. The consolidation of メディカルフロント as a subsidiary continues to be disclosed.
  24. FY2020-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 26 September 2019, the Company acquired shares in 株式会社メディカルフロント, an equity-method affiliate, and made it a consolidated subsidiary. The transaction took effect on 1 October 2019, on which date 株式会社メディカルフロント became a consolidated subsidiary of the Company.」

    The Company increased its voting rights in 株式会社メディカルフロント, which develops and sells systems and other products for the medical sector, from 37.1% to 51.3% and made it a consolidated subsidiary. Other businesses generated revenue of ¥135 million and a segment loss of ¥27 million in the first quarter.
  25. FY2019-Q3Higher revenue and wider losses in Other businessesAnnual report

    「In the cumulative consolidated period through the third quarter, Other businesses generated revenue of ¥470 million, up 16.1% year on year, and a segment loss of ¥9 million, compared with a segment loss of ¥2 million in the same period of the previous year.」

    Other businesses, including ミュートス's systems integration services and other activities, posted higher revenue, while the segment loss widened from ¥2 million to ¥9 million.
  26. FY2019-Q2Higher sales and a narrower loss in Other BusinessesAnnual report

    「In the cumulative consolidated period through the second quarter, Other businesses generated revenue of ¥321 million, up 25.0% year on year, and a segment loss of ¥0 million, down 88.0% from the segment loss of ¥5 million in the same period of the previous year.」

    Other businesses, including ミュートス's systems integration services and other activities, posted higher revenue, while the segment loss narrowed from ¥5 million in the same period of the previous year to ¥0 million.
  27. FY2019-Q1Higher revenue and wider losses in Other businessesAnnual report

    「In the cumulative consolidated period through the first quarter, Other businesses generated revenue of ¥148 million, up 91.0% year on year, and a segment loss of ¥12 million, compared with a segment loss of ¥1 million in the same period of the previous year.」

    Other businesses, including ミュートス's systems integration services and other activities, posted a substantial increase in revenue, while the segment loss widened from ¥1 million to ¥12 million.
  28. FY2018AdvancedAnnual report

    「Breakdown of assets and liabilities at the start of consolidation following the consolidation of 株式会社ミュートス…Voting rights acquired: 100%」

    The shares of ミュートス were acquired on 30 June 2017 and the company was consolidated as a wholly owned subsidiary. Its systems integration business for pharmaceutical companies was brought into the Group.
  29. FY2018-Q3Higher revenue and wider losses in Other businessesAnnual report

    「In the cumulative consolidated period through the third quarter, Other businesses generated revenue of ¥405 million, up 52.1% year on year, and a segment loss of ¥2 million, compared with a segment loss of ¥1 million in the same period of the previous year.」

    Revenue from Other businesses increased 52.1% year on year to ¥405 million, while the segment loss widened from ¥1 million to ¥2 million.
  30. FY2018-Q2First statedAnnual report

    「The main activities in Other businesses are systems integration services for pharmaceutical companies and other clients conducted by ミュートス, staffing services conducted by 株式会社レイケアセンター, a subsidiary of ファーマライズ株式会社, and sales of stationery and other products conducted by 新世薬品株式会社. In the cumulative consolidated period through the second quarter, Other businesses generated revenue of ¥257 million, up 46.7% year on year, and a segment loss of ¥5 million, compared with a segment loss of ¥1 million in the same period of the previous year.」

    Other businesses, including ミュートス's systems integration services for pharmaceutical companies and other clients, generated revenue of ¥257 million and a segment loss of ¥5 million.
Moved together

"Expanding Scale and Store Network through M&A and New Store Openings" moved the same way as this thread, in the same document, in 4 of its 30 moves.

4432★1234
  1. ★This thread
  2. 1Expanding Scale and Store Network through M&A and New Store Openings4×
  3. 2Profit improvement in the dispensing pharmacy business driven by an increase in prescriptions and fees for dispensing services4×
  4. 3Reliance on Borrowings and Risks Related to Interest Rates and Financial Covenants3×
  5. 4Subsidiary Reorganization and More Efficient Store Operations2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Pharmarise Holdings's next results are scheduled for 2026-09-17. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of Systems Integration Services for Pharmaceutical Companies | Pharmarise Holdings Corporation (2796) | Komori